Efstathios Kastritis, Irene Solia, Panagiotis Malandrakis, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Despina V Fotiou, Magd
In this issue of Blood Advances, Lontos1 et al provide a comprehensive report of the survival outcomes among 240 patients who underwent a transplant at…
In recent years, technological advancements have created new opportunities in hematology diagnostics. High-parameter cytometry methods have transformed the
Key Points. In Follicular lymphoma patients, both ctDNA and PET positivity after induction response are associated with shorter PFS.Only combined ctDNA and
In this issue of Blood Advances, Sendker et al1 report on a retrospective cohort of pediatric patients with therapy-related acute myeloid leukemia (tAML),
Thomas R. Collins is a medical journalist based in West Palm Beach, Florida. With measurable residual disease status (MRD) used as guidance, patients with newly…
Despite significant improvements in survival of patients with multiple myeloma (MM), outcomes remain heterogeneous, and a significant proportion of patients experience suboptimal outcomes. Importantly, traditional…
Previously, Collins et al identified distinct coagulopathic changes in a subset of women with severe postpartum hemorrhage (PPH; defined by blood loss >
In this issue of Blood Advances, Liu et al present a new mouse model of Diamond-Blackfan anemia (DBA) syndrome (see figure panel A).1 They use…
It is a common misperception that tyrosine kinase inhibitor (TKI) dosing in patients with chronic myeloid leukemia is very standard and straightforward. In
